YposKesi: Bioproduction specialist
YposKesi, developer of gene and cell therapy products for rare diseases, has appointed Alain Lamproye as its CEO. Lamproye, an expert in industrial bioproduction, most recently served as Chairman of the BioPharma Business Unit of Novaseps Belgian gene therapy subsidiary.
YposKesi was created in November 2016 by the nonprofit organisation AFM-Téléthon and the SPI fund managed by Bpifrance. The companys new head holds a Master of Sciences from the University of Liège. Before Novasep, Lamproye worked for 9 years in pharmaceutical operations at Merck Serono, where he held various managerial positions. Prior to that, he worked as GMP Production Director at Eurogentec for 14 years.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium